{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:06:10Z","timestamp":1786993570468,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virus Eradication"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jve.2023.100358","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T15:47:56Z","timestamp":1702309676000},"page":"100358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The importance of triple panel testing for hepatitis B and the burden of isolated anti-hepatitis B core antibodies within a community sample"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1876-2105","authenticated-orcid":false,"given":"Catherine","family":"Freeland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Sreepathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.","family":"Hass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Fenkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessie","family":"Torgersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Rothstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chari","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Gish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jve.2023.100358_bib1","author":"World Health Organization"},{"key":"10.1016\/j.jve.2023.100358_bib2","series-title":"Global Progress Report on HIV, Viral Hepatitis and Sexually Transmitted Infections","author":"World Health Organization","year":"2021"},{"issue":"1","key":"10.1016\/j.jve.2023.100358_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"key":"10.1016\/j.jve.2023.100358_bib4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/hep.31782","article-title":"An updated assessment of chronic hepatitis B prevalence among foreign-born persons living in the United States","volume":"74","author":"Wong","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jve.2023.100358_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/cld.728","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"12","author":"Terrault","year":"2018","journal-title":"Clin Liver Dis"},{"issue":"1","key":"10.1016\/j.jve.2023.100358_bib8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.7326\/M14-1018","article-title":"Screening for hepatitis B virus infection in nonpregnant adolescents and adults: U.S. Preventive services Task Force recommendation statement","volume":"161","author":"LeFevre","year":"2014","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.jve.2023.100358_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7201a1","article-title":"Screening and testing for hepatitis B virus infection: CDC recommendations-United States, 2023","volume":"72","author":"Conners","year":"2023","journal-title":"MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"issue":"2","key":"10.1016\/j.jve.2023.100358_bib10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3350\/cmh.2016.0024","article-title":"Prevention of hepatitis B reactivation in the setting of immunosuppression","volume":"22","author":"Pattullo","year":"2016","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"10.1016\/j.jve.2023.100358_bib11","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s11904-018-0379-y","article-title":"Significance and management of isolated hepatitis B core antibody (Anti-HBc) in HIV and HCV: strategies in the DAA era","volume":"15","author":"Chang","year":"2018","journal-title":"Curr HIV AIDS Rep"},{"issue":"3","key":"10.1016\/j.jve.2023.100358_bib12","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/infdis\/jiab366","article-title":"Estimated prevalence and number of persons with isolated antibody to hepatitis B core antigen and associated occult hepatitis B, United States, 2001-2018","volume":"225","author":"Spradling","year":"2022","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.jve.2023.100358_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9010202","article-title":"Isolated anti-HBc: significance and management","volume":"9","author":"Moretto","year":"2020","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.jve.2023.100358_bib14","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000321450","article-title":"Replicative activity of hepatitis B virus is negatively associated with methylation of covalently closed circular DNA in advanced hepatitis B virus infection","volume":"54","author":"Kim","year":"2011","journal-title":"Intervirology"},{"issue":"13","key":"10.1016\/j.jve.2023.100358_bib15","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.3748\/wjg.v22.i13.3531","article-title":"Genetic variation of occult hepatitis B virus infection","volume":"22","author":"Zhu","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"12","key":"10.1016\/j.jve.2023.100358_bib16","doi-asserted-by":"crossref","first-page":"860","DOI":"10.4254\/wjh.v6.i12.860","article-title":"Occult hepatitis B virus infection","volume":"6","author":"Kwak","year":"2014","journal-title":"World J Hepatol"},{"issue":"4","key":"10.1016\/j.jve.2023.100358_bib17","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/cld.883","article-title":"Reactivation of hepatitis B virus: a review of clinical guidelines","volume":"15","author":"Myint","year":"2020","journal-title":"Clin Liver Dis"},{"issue":"30","key":"10.1016\/j.jve.2023.100358_bib18","article-title":"Association between anti-HBc positivity and hepatocellular carcinoma in HBsAg-negative subjects with chronic liver disease: a meta-analysis","volume":"95","author":"Coppola","year":"2016","journal-title":"U S Med"},{"issue":"12","key":"10.1016\/j.jve.2023.100358_bib19","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/jvh.13365","article-title":"A predictive model for hepatitis B infection among high-risk adults using a community-based sample in greater Philadelphia","volume":"27","author":"Freeland","year":"2020","journal-title":"J Viral Hepat"},{"issue":"10","key":"10.1016\/j.jve.2023.100358_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/cells9102233","article-title":"Point-of-Care tests for hepatitis B: an overview","volume":"9","author":"Xiao","year":"2020","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.jve.2023.100358_bib21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.amjmed.2008.03.005","article-title":"Racial and ethnic variations in hepatocellular carcinoma incidence within the United States","volume":"121","author":"Wong","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.jve.2023.100358_bib22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1196\/annals.1425.007","article-title":"Health insurance and access to health care in the United States","volume":"1136","author":"Hoffman","year":"2008","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"10.1016\/j.jve.2023.100358_bib23","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/MLR.0b013e318185c913","article-title":"The causal effect of health insurance on utilization and outcomes in adults: a systematic review of US studies","volume":"46","author":"Freeman","year":"2008","journal-title":"Med Care"},{"issue":"1","key":"10.1016\/j.jve.2023.100358_bib24","doi-asserted-by":"crossref","DOI":"10.1186\/s13104-019-4287-z","article-title":"The prevalence and significance of isolated hepatitis B core antibody (anti-HBc) in endemic population","volume":"12","author":"Hyun","year":"2019","journal-title":"BMC Res Notes"},{"issue":"5","key":"10.1016\/j.jve.2023.100358_bib25","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/hep.27222","article-title":"Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?","volume":"60","author":"El-Serag","year":"2014","journal-title":"Hepatology (Baltimore, Md.)"}],"container-title":["Journal of Virus Eradication"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2055664023000444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2055664023000444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:12:19Z","timestamp":1761855139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2055664023000444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S2055664023000444"],"URL":"https:\/\/doi.org\/10.1016\/j.jve.2023.100358","relation":{},"ISSN":["2055-6640"],"issn-type":[{"value":"2055-6640","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The importance of triple panel testing for hepatitis B and the burden of isolated anti-hepatitis B core antibodies within a community sample","name":"articletitle","label":"Article Title"},{"value":"Journal of Virus Eradication","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jve.2023.100358","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100358"}}